|
Cold Spring Harbor Laboratory Cancer Research Center
|
2P01CA013106-46A1
|
$4,537,433
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$3,493,116
|
Restifo, Nicholas
|
CCR (NCI)
|
|
DF/HCC Kidney Cancer SPORE
|
5P50CA101942-14
|
$2,300,000
|
MCDERMOTT, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Duke SPORE in Brain Cancer
|
5P50CA190991-05
|
$2,300,000
|
SAMPSON, JOHN
|
DUKE UNIVERSITY
|
|
SPORE for Translational Approaches to Brain Cancer
|
1P50CA221747-01A1
|
$2,300,000
|
LESNIAK, MACIEJ
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
SPORE in Skin Cancer
|
5P50CA174523-05
|
$2,300,000
|
HERLYN, MEENHARD
|
WISTAR INSTITUTE
|
|
Nano Approaches to Modulate Host Cell Response for Cancer Therapy
|
5U54CA198999-04
|
$2,261,936
|
HUANG, LEAF
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
SPORE in Cervical Cancer
|
5P50CA098252-15
|
$2,251,770
|
WU, TZYY-CHOOU
|
JOHNS HOPKINS UNIVERSITY
|
|
Translational Research in Breast Cancer (SPORE)
|
5P50CA186784-05
|
$2,251,410
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Biology and Transplantation of the Hematopoietic Stem Cell
|
5P01CA065493-24
|
$1,914,832
|
WAGNER, JOHN
|
UNIVERSITY OF MINNESOTA
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,860,145
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Gene therapy of cancer
|
ZIA BC 010985
|
$1,860,145
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Innate Immune Responses and Vaccines Against Tumor-Associated Herpesviruses
|
5P01CA177322-05
|
$1,766,851
|
SUN, REN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Modeling bladder cancer pathogenesis and tumor evolution
|
1P01CA221757-01A1
|
$1,765,498
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
T-cell receptor gene therapy for cancer
|
ZIA BC 011479
|
$1,424,997
|
Hinrichs, Christian
|
CCR (NCI)
|
|
Center for Cell-based Therapy - Cures
|
ZIA BC 011855
|
$1,339,057
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Extracellular Vesicles (EVs) and Genes in the Biology and Therapy of Gliomas
|
5P01CA069246-21
|
$1,316,832
|
BREAKEFIELD, XANDRA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Telomere Biology
|
ZIA BC 011519
|
$1,187,757
|
Cooper, Julia
|
CCR (NCI)
|
|
Lambda Genetic Networks and Lambda Red-Mediated Recombination
|
ZIA BC 010336
|
$1,175,337
|
Court, Donald
|
CCR (NCI)
|
|
SPORE in Genitourinary Cancer
|
3P50CA091846-15S1
|
$1,162,609
|
DINNEY, COLIN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Initiation of DNA Replication in Mammalian Cells
|
ZIA BC 010411
|
$1,096,129
|
Aladjem, Mirit
|
CCR (NCI)
|
|
Molecular Basis of Cancer Virus Replication, Transformation, and Innate Defense
|
5P01CA016038-44
|
$980,728
|
DIMAIO, DANIEL
|
YALE UNIVERSITY
|
|
Harnessing the power of exosomes for non-coding RNA delivery
|
5R35CA209904-02
|
$905,873
|
SOOD, ANIL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
|
5R35CA197452-04
|
$904,242
|
FLORES, ELSA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Therapeutic Targeting of Malignant Glioma Stem Cells
|
5R35CA197725-05
|
$902,878
|
LESNIAK, MACIEJ
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Immuno-Targeted Therapy for Melanoma
|
5R35CA197633-04
|
$899,241
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cell Production Core Facility
|
ZIC BC 011569
|
$897,301
|
Somerville, Robert
|
CCR (NCI)
|
|
Surgery Branch Cell Prep Core
|
ZIC BC 010905
|
$897,301
|
Wunderlich, John
|
CCR (NCI)
|
|
Hematopoietic Chimerism after Stem Cell Allografts
|
5P01CA078902-20
|
$892,086
|
STORB, RAINER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Mechanism, Regulation and Application of miRNA pathway in cancer
|
ZIA BC 011566
|
$815,028
|
Gu, Shuo
|
CCR (NCI)
|
|
Nanoparticle-based targeted codelivery of siRNA and taxane to treat drug-resistant HER2+ breast cancer
|
4R44CA217534-02
|
$745,151
|
NGAMCHERDTRAKUL, WORAPOL
|
PDX PHARMACEUTICALS, LLC
|
|
Histone Methyltransferases as a Target for Lung Cancer Prevention
|
5R01CA183296-05
|
$731,519
|
BELINSKY, STEVEN
|
LOVELACE BIOMEDICAL & ENVIRONMENTAL RES
|
|
A Targeted Nanomedicine Prototype Against Enzalutamide-resistant Prostate Cancer
|
1R01CA226537-01
|
$673,092
|
PASQUALINI, RENATA
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Career Development in Pediatric and Medical Oncology
|
5K12CA076930-18
|
$672,442
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
AVGN7, a Novel Gene Therapeutic for Treating Cancer Cachexia
|
5R44CA221539-02
|
$660,235
|
RODGERS, BUEL
|
AAVOGEN, INC.
|
|
Mechanisms of Chromosome Maintenance in Bacteria
|
ZIA BC 010277
|
$610,807
|
Chattoraj, Dhruba
|
CCR (NCI)
|
|
Liver Cancer Risk with rAAV Gene Therapy
|
5R01CA190144-04
|
$586,035
|
GROMPE, MARKUS
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$584,807
|
Gottesman, Michael
|
CCR (NCI)
|
|
Clinical production of viral vectors for cancer gene therapy
|
ZIC BC 010989
|
$584,022
|
Beyer, Rachel
|
CCR (NCI)
|
|
Targeted therapy of B cell malignances with CAR-T cells of defined composition
|
5R01CA136551-10
|
$560,424
|
RIDDELL, STANLEY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.
|
5R01CA217179-02
|
$559,312
|
MARKERT, JAMES
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Adoptive T cell Therapy for Pediatric Leukemia
|
ZIA BC 011565
|
$546,995
|
Fry, Terry
|
CCR (NCI)
|
|
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas
|
5R01CA198076-04
|
$546,873
|
PORTNOW, JANA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
miR-155 targeted therapeutics for precision medicine in lung cancer
|
1R01CA222007-01A1
|
$536,674
|
CALIN, GEORGE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES
|
5T32CA009140-44
|
$517,563
|
PEAR, WARREN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Targeted Delivery of Brain Penetrating DNA Nanoparticles to Brain Tumors
|
5R01CA204968-03
|
$506,098
|
HANES, JUSTIN
|
JOHNS HOPKINS UNIVERSITY
|
|
Retroviral Replicating Vector-mediated Gene Therapy for Ovarian Cancer
|
5R01CA213119-02
|
$504,040
|
KASAHARA, NORIYUKI
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
UCLA Tumor Immunology Institutional Traning Grant
|
2T32CA009120-41A1
|
$497,990
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Image-guided radiation-induced permeability (IGRIP) for IGDD
|
5R01CA199663-04
|
$489,602
|
KRON, STEPHEN
|
UNIVERSITY OF CHICAGO
|
|
Mechanisms of resistance to ponatinib therapy in chronic myeloid leukemia
|
5R01CA178397-05
|
$483,771
|
O'HARE, THOMAS
|
UNIVERSITY OF UTAH
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|